The case involved a 43 year old breast cancer patient who was receiving
chemotherapy at dose administered 80 % higher than the standard.
Not exact matches
Chemotherapy drugs are usually administered to cancer patients every few weeks
at a high «maximum tolerated»
dose.
Conventional, high -
dose chemotherapy treatments can cause the fibroblast cells surrounding tumors to secrete proteins that promote the tumors» recurrence in more aggressive forms, researchers
at Taipei Medical University and the National Institute of Cancer Research in Taiwan and University of California, San Francisco, have discovered.
Frequent, low -
dose chemotherapy regimens avoid this effect and may therefore be more effective
at treating certain types of breast and pancreatic cancer, according to the murine study «Metronomic
chemotherapy prevents therapy - induced stromal activation and induction of tumor - initiating cells,» which will be published online November 23 in The Journal of Experimental Medicine.
A third group of mice received the standard high
dose of
chemotherapy at first, but once the animals» tumours started to shrink, the researchers dialled back the
dose.
Because AML is difficult to treat, standard treatment commonly involves multiple
chemotherapy medicines that are given
at a higher
dose in order to kill the cancer cells.
The safety study sets the stage for phase II clinical trials looking
at whether high
dose vitamin C is effective
at extending overall lifespan and quality of life for patients undergoing radiation and
chemotherapy.
Treating patients with high -
dose radiotherapy after
chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented
at ESMO 2014 Congress in Madrid.
This therapeutic effect was enhanced by combining the Angiopoietin - 2 antibody with a so - called metronomic
chemotherapy: In this kind of therapy, chemotherapeutic drugs are given continuously
at much lower
dose as in the classical high -
dose chemotherapy.
«Mesothelioma remains a difficult disease to find better treatment options for, so we asked whether high -
dose hemithoracic radiotherapy would decrease the rate or delay the time of local recurrence after
chemotherapy and radical surgery,» says lead author Prof Rolf A. Stahel, from the Clinic and Policlinic for Oncology,
at the University Hospital Zurich, Switzerland, and current President of the European Society for Medical Oncology.
Methotrexate is already used as a
chemotherapy drug for several types of cancer, and this early research shows that
at much lower
doses it could have the potential to help treat certain blood disorders.»
It is also used in some cancers
at much higher
doses where the side effects are substantial and similar to other
chemotherapy agents.
Those with uninformative cytogenetic or molecular markers with negative minimal residual disease
at the end of induction were noted to experience the most benefit (nearly 2-fold benefit from receiving a fifth
dose of
chemotherapy) vs. those with favorable cytogenetic and molecular features who did not experience benefit from receiving a fifth
dose of therapy.
DNA interstrand crosslinks (ICLs) are highly toxic DNA lesions that can form endogenously but are also induced
at high
doses in cancer
chemotherapy.
Many studies have shown that
at high
doses, vitamin C is toxic to cancer cells, able to work synergistically with conventional therapies such as
chemotherapy and radiation.
In fact
at the
doses used, the
chemotherapy is not having direct cytotoxic activity, i.e. not directly killing the cancer cells.
Metronomic
chemotherapy is a low
dose at high frequency that lowers toxicity and is aimed
at the tumor.
She has since undergone surgery
at B.C. Children's Hospital to remove a tumour, but Paige still needs to receive high
dose chemotherapy treatment for the next six to eight months.